FAAH and Alzheimer disease: In agreement with these data, the key PEA-hydrolyzing enzyme, FAAH, is significantly up-regulated in peripheral monocytes isolated from AD patients, and its level correlates with the severity of the disease, suggesting that PEA signaling is impaired during AD progression [17].